Latest news
Transfer of Marketing Authorization of Anticancer Drug Elplat® to Takata Pharmaceutical
Debiopharm International SA Appeals to the Supreme Court regarding Towa Pharmaceutical Co., Ltd. case
Debiopharm International SA Appeals to the Supreme Court regarding Nippon Kayaku Co., Ltd. case
Yakult Honsha Co., Ltd. and Debiopharm International SA File Patent Infringement for Elplat® against Nippon Kayaku Co., Ltd.
Debiopharm International SA has won its Patent Infringement Suit for Elplat® against Nippon Kayaku Co., Ltd.
Debiopharm International SA’s partner Yakult Honsha Co, Ltd. announces Elplat® approbation in gastric cancer in Japan
Debiopharm´s Eloxatin® (Oxaliplatin) awarded Prix Galien in France for innovative cancer therapy
Yakult Honsha files Initial Submission for Marketing Authorisation of Debiopharm´s Oxaliplatin in Japan